• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

D-二聚体、凝血酶-抗凝血酶复合物与住院患者血栓栓塞风险因素。

D-dimers, thrombin-antithrombin complexes, and risk factors for thromboembolism in hospitalized patient.

机构信息

Department of Internal Medicine, Nantes University-Hospital Centre, Nantes, France.

出版信息

Clin Appl Thromb Hemost. 2009 Dec;15(6):666-75. doi: 10.1177/1076029608321436. Epub 2008 Sep 15.

DOI:10.1177/1076029608321436
PMID:18796458
Abstract

INTRODUCTION

There is lack of data about the correlation between hemostatic markers and the clinical and biological risk factors (RFs) for venous thromboembolism (VTE) in medical inpatients without suspicion of acute VTE.

MATERIAL AND METHODS

To evaluate the coagulation activation status in patients with current known RFs for VTE, the authors measured 2 markers of hypercoagulability, thrombin antithrombin (TAT) complexes and D-dimers, at day 1 in 165 patients hospitalized in internal medicine wards without suspected acute VTE. All known RFs for VTE were systematically assessed at admission and classified in a chronological way as permanent or transient.

RESULTS

Surprisingly, TAT values followed a multimodal distribution. D-dimers showed a normal distribution after a logarithmic transformation (P = .34, Shapiro-Wilk test). Interestingly, a significant progression in D-dimer levels was found according to the chronological classification of RFs. D-dimer variations on multivariate analysis (not applicable for TAT because of the multimodal distribution) correlated independently with a recent inability to walk and an increase in C reactive protein level more than 10 mg/L.

CONCLUSIONS

(a) this study is the first to describe the variations of hypercoagulability markers according to a systematic screening of RFs for VTE in inpatients without suspicion of acute VTE, (b) TAT appeared as a less relevant marker of hypercoagulability than D-dimers in internal medicine inpatients, (d) the chronological classification of RFs identified clearly groups at risk for the prethrombotic state, and (d) an increased hypercoagulability state was demonstrated in patients with an association between a recent immobility and increased inflammatory markers.

摘要

简介

缺乏关于无急性静脉血栓栓塞症(VTE)疑诊的住院内科患者止血标志物与静脉血栓栓塞症(VTE)临床和生物学危险因素(RFs)之间相关性的数据。

材料与方法

为评估当前已知 VTE 风险因素患者的凝血激活状态,作者在 165 例无急性 VTE 疑诊的住院内科患者中,于入院第 1 天检测了 2 种高凝标志物:凝血酶-抗凝血酶(TAT)复合物和 D-二聚体。所有已知的 VTE RFs 均在入院时进行了系统评估,并按时间顺序分类为永久性或暂时性。

结果

出乎意料的是,TAT 值呈多峰分布。D-二聚体经对数转换后呈正态分布(P =.34,Shapiro-Wilk 检验)。有趣的是,根据 RFs 的时间顺序分类,D-二聚体水平呈显著进展。在多变量分析中,D-二聚体的变化(由于 TAT 的多峰分布而不适用于 TAT)与近期无法行走和 C 反应蛋白水平升高超过 10mg/L 独立相关。

结论

(a)本研究首次描述了无急性 VTE 疑诊的住院内科患者中,根据 VTE RFs 的系统筛查,高凝标志物的变化;(b)与住院内科患者相比,TAT 似乎是一种不太相关的高凝标志物;(c)RFs 的时间顺序分类明确确定了处于血栓前状态风险的组;(d)近期活动能力下降和炎症标志物升高的患者表现出高凝状态增加。

相似文献

1
D-dimers, thrombin-antithrombin complexes, and risk factors for thromboembolism in hospitalized patient.D-二聚体、凝血酶-抗凝血酶复合物与住院患者血栓栓塞风险因素。
Clin Appl Thromb Hemost. 2009 Dec;15(6):666-75. doi: 10.1177/1076029608321436. Epub 2008 Sep 15.
2
Coagulation activation markers do not correlate with the clinical risk of thrombosis in pregnant women.凝血激活标志物与孕妇血栓形成的临床风险无关。
Am J Obstet Gynecol. 2001 Feb;184(3):382-9. doi: 10.1067/mob.2001.109397.
3
Haemostatic factors and the risk of cardiovascular death in patients with coronary artery disease: the AtheroGene study.止血因子与冠状动脉疾病患者心血管死亡风险:动脉粥样基因研究
Arterioscler Thromb Vasc Biol. 2006 Dec;26(12):2793-9. doi: 10.1161/01.ATV.0000249406.92992.0d. Epub 2006 Oct 5.
4
Influence of aging on the activity of the hemostatic system: prothrombin fragment 1+2, thrombin-antithrombin III complexes and D-dimers in 80 healthy subjects with age ranging from 20 to 94 years.衰老对止血系统活性的影响:80名年龄在20至94岁之间的健康受试者的凝血酶原片段1+2、凝血酶-抗凝血酶III复合物及D-二聚体
Nouv Rev Fr Hematol (1978). 1992;34(1):43-6.
5
TAT, F1 + 2, and D-dimer levels in patients after coronary angiography with nonionic or ionic contrast media or after cardiac catheterization.接受非离子型或离子型造影剂冠状动脉造影术后或心导管插入术后患者的凝血酶原时间(TAT)、F1 + 2和D - 二聚体水平。
Semin Thromb Hemost. 1996;22 Suppl 1:61-5.
6
[Activation of hemostasis in patients with chronic cholecystitis].
Pol Merkur Lekarski. 2001 Jan;10(55):19-20.
7
[Predictive value of coagulative molecular markers for thromboembolism in patients with nonvalvular atrial fibrillation: prospective five-year follow-up study].[非瓣膜性心房颤动患者血栓栓塞的凝血分子标志物预测价值:前瞻性五年随访研究]
J Cardiol. 2004 Dec;44(6):223-32.
8
The effect of dalteparin on coagulation activation during pregnancy in women with thrombophilia. A randomized trial.达肝素对血栓形成倾向女性孕期凝血激活的影响。一项随机试验。
Thromb Haemost. 2007 Jul;98(1):163-71.
9
Markers of coagulation activation, endothelial stimulation and inflammation in patients with peripheral arterial disease.外周动脉疾病患者凝血激活、内皮刺激和炎症的标志物。
Eur J Vasc Endovasc Surg. 2005 Feb;29(2):171-6. doi: 10.1016/j.ejvs.2004.11.001.
10
Increased hemostatic molecular markers in patients undergoing anticoagulant therapy.接受抗凝治疗患者的止血分子标志物增加。
Semin Thromb Hemost. 2000;26(1):113-8. doi: 10.1055/s-2000-9813.

引用本文的文献

1
D-dimer Levels in Acute, Medically Ill, Hospitalized Patients: A Large, Prospective, Multicenter Study in the United States.美国急性内科疾病住院患者的D-二聚体水平:一项大型前瞻性多中心研究
Clin Appl Thromb Hemost. 2025 Jan-Dec;31:10760296251320406. doi: 10.1177/10760296251320406.
2
Clinical study on the feasibility of new thrombus markers in predicting massive cerebral infarction.新型血栓标志物预测大面积脑梗死可行性的临床研究
Front Neurol. 2023 Jan 25;13:942887. doi: 10.3389/fneur.2022.942887. eCollection 2022.
3
Thromboembolic disease in patients with rheumatoid arthritis undergoing joint arthroplasty: Update on prophylaxes.
类风湿关节炎患者行关节置换术时的血栓栓塞性疾病:预防措施的最新进展。
World J Orthop. 2014 Nov 18;5(5):645-52. doi: 10.5312/wjo.v5.i5.645.
4
Long-term efficacy and safety of eculizumab in Japanese patients with PNH: AEGIS trial.依库珠单抗治疗日本阵发性睡眠性血红蛋白尿症患者的长期疗效和安全性:AEGIS 试验。
Int J Hematol. 2013 Oct;98(4):406-16. doi: 10.1007/s12185-013-1404-y. Epub 2013 Aug 11.
5
[Alternative sonographic diagnoses in patients with clinical suspicion of deep vein thrombosis].
Med Klin (Munich). 2010 Sep;105(9):619-26. doi: 10.1007/s00063-010-1101-z. Epub 2010 Sep 28.